Private company
Bionor Pharma
Norwegian biotechnology company (1993-2017)
Bionor Holding AS is a Norwegian biotechnology company, developing vaccines targeted at rapidly mutating virus infections such as HIV, Hepatitis C and Influenza. The company is also a leader in soy technology and has developed patented products for improved health and prevention of lifestyle-related diseases.2 Wikipedia text CC BY-SA 4.0
Last updated Oct 21, 2026.
Overview
- Industrybiotechnology1
- HeadquartersOslo1
- Websitewww.bionorpharma.com/en
- Legal formaksjeselskap1
- Listed onOslo Stock Exchange1
- LEI2549009SYPDM9Y2627253
- StatusActive3
- LEI statusLapsed (not renewed)3
- Registered addressKarenslyst Alle 6, 0278 Oslo, Norway3
- Registered withThe Brønnøysund Register Centre, 919 282 1343
See how the biggest companies compare on our leaderboards
Bionor Holding AS is a Norwegian biotechnology company, developing vaccines targeted at rapidly mutating virus infections such as HIV, Hepatitis C and Influenza. The company is also a leader in soy technology and has developed patented products for improved health and prevention of lifestyle-related diseases.2
Products and brands
- vaccine
Listed on Wikidata.1
Timeline
Links
- Websitewww.bionorpharma.com/en1
- WikipediaBionor Pharma
- WikidataQ12646423
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataBionor Pharma on Wikidata
- 2WikipediaBionor Pharma on Wikipedia
- 3